Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE
Clinical trial NCT04643067 · COMPLETED
Trial details
- NCT number
- NCT04643067
- Sponsor
- Kangpu Biopharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2023-08-18
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.